News
The mining of rare diseases | Pharma's Windfall | The Seattle Times
apps.seattletimes.com
The mining of rare diseases. Thirty years ago, Congress acted to spur research on rare diseases. Today, we have hundreds of new drugs — along with runaway pricing and market manipulation, as drugmakers turn a law with good intentions into a profit engine — Jessica O'Dell. In the fall of 2011, a cancer physician at Seattle Children’s ...
sortiert nach Relevanz / Datum